Familial urticaria pigmentosa: Report of a family and review of the role of KIT mutations

American Journal of Dermatopathology

Volumn 35, Issue 1, 2013, Pages 113-116

  Fett, Nicole M ^a,b   Teng, Joyce ^c   Longley, B Jack ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

c kit protooncogene; KIT tyrosine kinase; Mastocytosis; Urticarial pigmentosa

Indexed keywords

ADULT; ANAMNESIS; BONE MARROW BIOPSY; CASE REPORT; CHILD; CLINICAL FEATURE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; ONCOGENE C KIT; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; URTICARIA PIGMENTOSA;

ADULT; BIOPSY; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; MALE; MUTATION; PEDIGREE; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT; SKIN; URTICARIA PIGMENTOSA;

EID: 84873412121     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31826330bf     Document Type: Review

References (22)

1. Yang Y, Letard S, Borge L, et al. Pediatric mastocytosis-Associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood. 2010;116:1114-1123.
2. Orfao A, Garcia-Montero AC, Sanchez L, et al. Recent advances in the understanding of mastocytosis: The role of KIT mutations. Br J Haematol. 2007;138:12-30.
3. Kitamura Y, Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci. 2004;61:2924-2931.
4. Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest. 1993;92:1736-1744.
5. Longley BJ Jr, Metcalfe DD, Tharp M, et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A. 1999;96:1609-1614.
6. Longley BJ, Tyrrell L, Lu SZ, et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet. 1996;12:312-314.
7. Bodemer C, Hermine O, Palmerini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol. 2010;130:804-815.
8. Yanagihori H, Oyama N, Nakamura K, et al. c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. J Mol Diagn. 2005;7:252-257.
9. Verzijl A, Heide R, Oranje AP, et al. C-kit Asp-816-Val mutation analysis in patients with mastocytosis. Dermatology. 2007;214:15-20.
10. Daley T, Metcalfe DD, Akin C. Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin. Blood. 2001;98:880-882.
11. Sato-Matsumura KC, Matsumura T, Koizumi H, et al. Analysis of c-kit exon 11 and exon 17 of urticaria pigmentosa that occurred in monozygotic twin sisters. Br J Dermatol. 1999;140:1130-1132.
12. Sotta PD, Romero WA, Kramer D, et al. Cutaneous mastocytosis in twins: Multiple mastocytomas and urticaria pigmentosa in two pairs of monozygotic twins. Pediatr Dermatol. 2011;28:585-587.
13. Tang X, Boxer M, Drummond A, et al. A germline mutation in KIT in familial diffuse cutaneous mastocytosis. J Med Genet. 2004;41:e88.
14. Chang A, Tung RC, Schlesinger T, et al. Familial cutaneous mastocytosis. Pediatr Dermatol. 2001;18:271-276.
15. Fowler JF Jr, Parsley WM, Cotter PG. Familial urticaria pigmentosa. Arch Dermatol. 1986;122:80-81.
16. Clark DP, Buescher L, Havey A. Familial urticaria pigmentosa. Arch Intern Med. 1990;150:1742-1744.
17. Anstey A, Lowe DG, Kirby JD, et al. Familial mastocytosis: A clinical, immunophenotypic, light and electron microscopic study. Br J Dermatol. 1991;125:583-587.
18. Rosbotham JL, Malik NM, Syrris P, et al. Lack of c-kit mutation in familial urticaria pigmentosa. Br J Dermatol. 1999;140:849-852.
19. Hartmann K, Wardelmann E, Ma Y, et al. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology. 2005;129:1042-1046.
20. Zhang LY, Smith ML, Schultheis B, et al. A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy. Leuk Res. 2006;30:373-378.
21. Beghini A, Tibiletti MG, Roversi G, et al. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer. 2001;92: 657-662.
22. Pardanani A, Reeder TL, Kimlinger TK, et al. Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. Leuk Res. 2003;27:739-742.